(R,E)-N-((3-CHLOROPYRIDIN-2-YL)METHYLENE)-2-METHYLPROPANE-2-SULFINAMIDE

Catalog No. :
ACYKKL206
CAS No. :
1421236-61-4
Molecular Formula :
C10H13ClN2OS
Molecular Weight :
244.75

IUPAC Name:(R,E)-N-((3-chloropyridin-2-yl)methylene)-2-methylpropane-2-sulfinamide

(R,E)-N-((3-CHLOROPYRIDIN-2-YL)METHYLENE)-2-METHYLPROPANE-2-SULFINAMIDE structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$157.00Login to see priceInquiryInquiry
1g95%$393.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R,E)-N-((3-CHLOROPYRIDIN-2-YL)METHYLENE)-2-METHYLPROPANE-2-SULFINAMIDE
IUPAC Name(R,E)-N-((3-chloropyridin-2-yl)methylene)-2-methylpropane-2-sulfinamide
MDL No.MFCD30828975
Molecular FormulaC10H13ClN2OS
Molecular Weight244.75
SMILESCC(C)(C)[S@@](=O)/N=C/C1=NC=CC=C1Cl
InChI KeyBTUUNHWXZRCLLJ-MYWXAZLQSA-N
Synonym2-Propanesulfinamide, N-[(3-chloro-2-pyridinyl)methylene]-2-methyl-, [N(E),S(R)]-
CAS No.1421236-61-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYKKL206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEIHU089 route compound structure diagram
    ACEIHU089196929-78-9 In Stock
  2. Plus
  3. ACBNDF296 route compound structure diagram
    ACBNDF296206181-90-0 In Stock
  4. Then
  5. ACYKKL206 route product structure diagram
    ACYKKL2061421236-61-4
Inquiry

2. ACYKKL206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFINB315 route compound structure diagram
    ACFINB31577332-89-9 In Stock
  4. Then
  5. ACYKKL206 route product structure diagram
    ACYKKL2061421236-61-4
Inquiry

Comments (0)